Molecular Templates, Inc.
Molecular Templates, Inc. (MTEM) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
mtem · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Molecular Templates, Inc.You MTEM | $0M | N/A | — | -$1.80 |
 ACI Global Corporation ACGJ | $0M | N/A | — | — |
 Allena Pharmaceuticals, Inc. ALNAQ | $0M | N/A | — | -$0.73 |
 Arch Therapeutics, Inc. ARTH | $0M | N/A | — | -$2.27 |
 Beleave Inc. BLEVF | $0M | N/A | — | -$0.08 |
 EPIRUS Biopharmaceuticals, Inc. EPRSQ | $0M | N/A | — | — |
 IMV Inc. IMVIQ | $0M | N/A | — | -$4.55 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Molecular Templates, Inc. (MTEM) measures how much investors pay for each dollar of the company's trailing earnings. MTEM's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$1.80.
Frequently asked questions
MTEM pe ratio · 6 questionsMTEM's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$1.80. Data sourced from Financial Modeling Prep via MTEM's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Molecular Templates, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09